The National Research Council of Canada said Tuesday it will work with a Chinese company to try to develop its potential vaccine for COVID-19 more quickly. The Chinese company, CanSino Biologics, is already conducting human clinical trials for its vaccine. As of April, five vaccine candidates have moved into clinical development in early stage human trials, including CanSino's, called Ad5-nCoV. The NRC plans to use a cell line its scientists developed during Ebola vaccine research. He isn't involved in the vaccine trials.

Source: CBC News May 12, 2020 17:52 UTC